Skorpen F - Search Results

1

Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids.

Laugsand EA, Fladvad T, Skorpen F, Maltoni M, Kaasa S, Fayers P, Klepstad P. Laugsand EA, et al. Among authors: skorpen f. Eur J Cancer. 2011 Jul;47(11):1682-91. doi: 10.1016/j.ejca.2011.04.014. Epub 2011 May 12. Eur J Cancer. 2011. PMID: 21570824

2

Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.

Holthe M, Klepstad P, Zahlsen K, Borchgrevink PC, Hagen L, Dale O, Kaasa S, Krokan HE, Skorpen F. Holthe M, et al. Among authors: skorpen f. Eur J Clin Pharmacol. 2002 Aug;58(5):353-6. doi: 10.1007/s00228-002-0490-1. Epub 2002 Jul 13. Eur J Clin Pharmacol. 2002. PMID: 12185559 Clinical Trial.

3

Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients.

Holthe M, Rakvåg TN, Klepstad P, Idle JR, Kaasa S, Krokan HE, Skorpen F. Holthe M, et al. Among authors: skorpen f. Pharmacogenomics J. 2003;3(1):17-26. doi: 10.1038/sj.tpj.6500139. Pharmacogenomics J. 2003. PMID: 12629580

4

Genetic analysis of the murine mu opioid receptor: increased complexity of Oprm gene splicing.

Kvam TM, Baar C, Rakvåg TT, Kaasa S, Krokan HE, Skorpen F. Kvam TM, et al. Among authors: skorpen f. J Mol Med (Berl). 2004 Apr;82(4):250-5. doi: 10.1007/s00109-003-0514-z. Epub 2004 Jan 9. J Mol Med (Berl). 2004. PMID: 14991152

5

The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.

Klepstad P, Rakvåg TT, Kaasa S, Holthe M, Dale O, Borchgrevink PC, Baar C, Vikan T, Krokan HE, Skorpen F. Klepstad P, et al. Among authors: skorpen f. Acta Anaesthesiol Scand. 2004 Nov;48(10):1232-9. doi: 10.1111/j.1399-6576.2004.00517.x. Acta Anaesthesiol Scand. 2004. PMID: 15504181

6

The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.

Rakvåg TT, Klepstad P, Baar C, Kvam TM, Dale O, Kaasa S, Krokan HE, Skorpen F. Rakvåg TT, et al. Among authors: skorpen f. Pain. 2005 Jul;116(1-2):73-8. doi: 10.1016/j.pain.2005.03.032. Pain. 2005. PMID: 15927391

7

Genetic variability and clinical efficacy of morphine.

Klepstad P, Dale O, Skorpen F, Borchgrevink PC, Kaasa S. Klepstad P, et al. Among authors: skorpen f. Acta Anaesthesiol Scand. 2005 Aug;49(7):902-8. doi: 10.1111/j.1399-6576.2005.00772.x. Acta Anaesthesiol Scand. 2005. PMID: 16045647 Review.

8

[Genetic variation-- important for the clinical effect of opioids?].

Klepstad P, Dale O, Borchgrevink PC, Kaasa S, Skorpen F. Klepstad P, et al. Among authors: skorpen f. Tidsskr Nor Laegeforen. 2005 Oct 6;125(19):2655-8. Tidsskr Nor Laegeforen. 2005. PMID: 16215614 Free article. Norwegian.

9

Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.

Reyes-Gibby CC, Shete S, Rakvåg T, Bhat SV, Skorpen F, Bruera E, Kaasa S, Klepstad P. Reyes-Gibby CC, et al. Among authors: skorpen f. Pain. 2007 Jul;130(1-2):25-30. doi: 10.1016/j.pain.2006.10.023. Epub 2006 Dec 6. Pain. 2007. PMID: 17156920 Free PMC article.

10

Variable response to opioid treatment: any genetic predictors within sight?

Skorpen F, Laugsand EA, Klepstad P, Kaasa S. Skorpen F, et al. Palliat Med. 2008 Jun;22(4):310-27. doi: 10.1177/0269216308089302. Palliat Med. 2008. PMID: 18541635 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters